Disease/Infection News

RSS

New test enables accurate, rapid testing of Salmonella bacteria

A new test allows accurate, rapid testing for Salmonella, a bacteria that is one of the leading causes of food-borne illness across all regions of the world. Salmonella can infect animals as well as people, with commonly reported cases of people falling sick after handling pets and livestock.

5 Oct 2017

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

The National Institutes of Health announced today that microbiologist Sloan Siegrist at the University of Massachusetts Amherst has received a five-year, $2.3 million National Institutes of Health New Innovator Award, which supports "unusually innovative research from early career investigators," to study the bacterium that causes tuberculosis (TB).

5 Oct 2017

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.

5 Oct 2017

GW researcher awarded NIH grant to study how cocaine use affects HIV infection

Following studies showing that cocaine influences the replication and transcription of HIV, a researcher at the George Washington University School of Medicine and Health Sciences was awarded more than $2.3 million from the National Institutes of Health to look deeper into the involved molecular mechanisms that allow this effect to happen.

5 Oct 2017

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

A collaborative study conducted by the Miller School of Medicine, University of Miami has revealed that a monoclonal antibody “cocktail” inhibited zika virus (ZIKV) infection in primates.

5 Oct 2017

Scientists develop synthetic molecule effective at kicking and killing HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly reduce the chance of transmission from person to person.

5 Oct 2017

Scientists develop novel weapon to combat deadly hospital-acquired infections

Scientists have developed a novel weapon in the battle against deadly hospital-acquired infections - a textile that disinfects itself.

5 Oct 2017

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University of Pennsylvania, conducted in partnership with The Wistar Institute, Inovio Pharmaceuticals, and GeneOne Life Science, Inc.

5 Oct 2017

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E. coli and Salmonella, new University of Colorado Boulder research shows.

4 Oct 2017

Symprove could offer safe and efficient solution to control pathogenic bacteria

Leading food technology company, Symprove Ltd, has demonstrated with three breakthrough studies that their formula has the unique ability to have an antagonistic effect on pathogenic bacteria such as C. difficile, Escherichia coli (AIEC), Shigella sonnei and MRSA.

4 Oct 2017

GTFCC launches new strategy to reduce cholera deaths by 90% by 2030

An ambitious new strategy to reduce deaths from cholera by 90% by 2030 will be launched tomorrow by the Global Task Force on Cholera Control, a diverse network of more than 50 UN and international agencies, academic institutions, and NGOs that supports countries affected by the disease.

4 Oct 2017

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

The microscopic parasite Giardia can be found within Idaho, every region of the U.S. and around the world. While Giardia is not considered fatal, anyone who has suffered from the diarrheal disease knows how uncomfortable it can be.

3 Oct 2017

Study identifies inadvertent consequences of sepsis care programs

Healthcare experts have long known the benefits of integrated sepsis care programs, yet less information has been published on potential unintended consequences of these programs.

3 Oct 2017

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn't qualify yet for the Medicaid program's criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

3 Oct 2017

Statin use linked to reduced risk of S aureus bloodstream infection

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings.

3 Oct 2017

BSACI’s new guidelines enhance diagnosis and management of peanut allergy

A new guideline published recently by the Standards of Care Committee of the British Society for Allergy & Clinical Immunology (BSACI) aims to bring together the latest science in order to improve the diagnosis and management of peanut and tree nut allergy.

30 Sep 2017

British technology offers ultimate surface protection against Aussie flu virus

With breaking news of a more severe Aussie Flu strain heading for the UK, there is a British technology that provides the ultimate surface protection against the virus - reducing it by 99.99%!

30 Sep 2017

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

WHAT: Using genetically modified (GM) mosquitoes to reduce or prevent the spread of infectious diseases is a new but rapidly expanding field of investigation.

30 Sep 2017

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

University of Hawaii vaccine researcher Axel Lehrer, PhD, has received a nearly $6.3 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.

28 Sep 2017

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

28 Sep 2017

Disease/Infection News

New test enables accurate, rapid testing of Salmonella bacteria

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

Antibody-based Zika virus therapeutic protects monkeys from infection, study shows

GW researcher awarded NIH grant to study how cocaine use affects HIV infection

Monoclonal antibody “cocktail” inhibits Zika infection, study reveals

Scientists develop synthetic molecule effective at kicking and killing HIV

Scientists develop novel weapon to combat deadly hospital-acquired infections

New DNA-based Zika vaccine demonstrates safety and ability to elicit immune response

Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics

Symprove could offer safe and efficient solution to control pathogenic bacteria

GTFCC launches new strategy to reduce cholera deaths by 90% by 2030

Researchers awarded NIH grant to develop, test new drugs for treating Giardia infections

Study identifies inadvertent consequences of sepsis care programs

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

Statin use linked to reduced risk of S aureus bloodstream infection

BSACI’s new guidelines enhance diagnosis and management of peanut allergy

British technology offers ultimate surface protection against Aussie flu virus

GM mosquitoes can have altered microbiota that suppresses human malaria-causing parasites

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News